Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma(,,)

OBJECTIVE: Uterine carcinosarcoma (CS) is a rare uterine tumor with an extremely poor prognosis. In the adjuvant setting, efficacy has been shown with radiotherapy (RT), systemic chemotherapy, or both. This is the first report describing the efficacy and toxicity of adjuvant ifosfamide or ifosfamide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Einstein, Mark H., Klobocista, Merieme, Hou, June Y., Lee, Stephen, Mutyala, Subhakar, Mehta, Keyur, Reimers, Laura L., Kuo, Dennis Y.-S., Huang, Gloria S., Goldberg, Gary L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787514/
https://ncbi.nlm.nih.gov/pubmed/22055846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados